scispace - formally typeset
T

Thomas Powles

Researcher at Queen Mary University of London

Publications -  804
Citations -  57482

Thomas Powles is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Medicine & Cancer. The author has an hindex of 82, co-authored 655 publications receiving 39271 citations. Previous affiliations of Thomas Powles include Charing Cross Hospital & University of London.

Papers
More filters
Journal ArticleDOI

Immune Checkpoint Inhibition in Metastatic Urothelial Cancer

TL;DR: Predictive biomarkers are needed to go beyond PD-L1 expression, which is showing inconsistent results across trials.
Journal ArticleDOI

Axitinib plus immune checkpoint inhibitor: evidence- and expert-based consensus recommendation for treatment optimisation and management of related adverse events.

TL;DR: This work addressed areas of AEs requiring unique management during treatment with axitinib–ICI combinations that were not covered by current recommendations and focused on AEs with an overlap between axit inib and ICI therapy.
Journal ArticleDOI

Genitourinary tumors, non-prostate

Alain Ravaud, +698 more
- 01 Sep 2012 - 
TL;DR: Combining BEV with the mTOR inhibitor EVE may be an efficacious and well-tolerated treatment option for mRCC and PFS and tolerability were similar for first-line EVE +-BEV and IFN + BEV.